Hironobu Shibata
Overview
Explore the profile of Hironobu Shibata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kano M, Shibata H, Hiroshima Y, Kinoshita H, Chikugo F
Kyobu Geka
. 2024 Aug;
77(8):590-592.
PMID: 39205412
Multiple myeloma (MM) is a disease with a poor prognosis, and there are few reports of cardiac surgery complicated by this disease, which can lead to various perioperative complications such...
2.
Tokuda S, Sakamoto K, Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, et al.
Rinsho Ketsueki
. 2024 Jul;
65(6):492-497.
PMID: 38960646
A 69-year-old man presented with lumbago and was diagnosed with multiple myeloma (IgD-λ type, R-ISS stage II) with bone-destructive lesions in the lumbar spine and sacrum. Chromosome analysis showed t...
3.
Ozaki S, Iima T, Sekimoto E, Shibata H, Shigekiyo T, Higuchi Y, et al.
EJHaem
. 2023 May;
4(2):483-487.
PMID: 37206285
Systemic osteosclerosis is a rare complication of hematological malignancies. Primary myelofibrosis and acute megakaryocytic leukemia are known as underlying diseases; however, lymphoid tumors have rarely been reported. Here we describe...
4.
Kageyama T, Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, Shibata H, et al.
Rinsho Ketsueki
. 2023 Apr;
64(3):198-202.
PMID: 37019673
The patient is a 45-year-old man who was diagnosed with severe hemophilia A during childhood and received FVIII replacement therapy, which became ineffective due to inhibitor production (5-225 BU/ml). After...
5.
Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, Sekimoto E, Shibata H, et al.
Int J Hematol
. 2023 Jan;
117(5):718-728.
PMID: 36692689
High-risk cytogenetic abnormalities (HRCAs) are the most critical factor affecting prognosis in multiple myeloma (MM). However, the clinical significance of HRCAs in routine practice has not been fully elucidated. We...
6.
Ozaki S, Umeda H, Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, et al.
EJHaem
. 2022 Dec;
3(4):1418-1419.
PMID: 36467829
No abstract available.
7.
Ozaki S, Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, Shibata H, et al.
Am J Hematol
. 2022 Aug;
97(11):1497-1500.
PMID: 35957554
No abstract available.
8.
Sei M, Mizuguchi M, Yagi H, Kagawa K, Sekimoto E, Shibata H, et al.
Rinsho Ketsueki
. 2022 Aug;
63(7):733-739.
PMID: 35922940
Acquired factor V deficiency is a rare disease that presents with various bleeding symptoms because of the acquired production of factor V inhibitors and decrease in factor V activity. We...
9.
Shigekiyo T, Yagi H, Sekimoto E, Shibata H, Ozaki S, Tamura T
Thromb Res
. 2020 May;
191:30-33.
PMID: 32361514
No abstract available.
10.
Ozaki S, Harada T, Yagi H, Sekimoto E, Shibata H, Shigekiyo T, et al.
Cancers (Basel)
. 2019 Dec;
12(1).
PMID: 31861479
We retrospectively analyzed multiple myeloma (MM) patients who underwent autologous stem cell transplantation (ASCT) without maintenance therapy to assess the impact of recovery of normal immunoglobulin (Ig) on clinical outcomes....